Lyell Immunopharma, Inc. (LYEL) — Institutional Ownership     Insider Trades

Lyell Immunopharma, Inc. (LYEL) — among the top institutional holders, 1 hedge funds and asset managers reported positions as of Q42025. In Q42025, 0 funds opened a new position, 1 increased their stake, and 0 reduced their holdings. The largest holder is Decheng Capital LLC with 692.05K shares valued at $ 21.3M.